Compound ID | 2115
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Fatty acid synthesis inhibitor. Binds FabH, FabB and FabF; FabH/ FabB/ FabF inhibitor |
| Target Pathogen: | Active against Escherichia coli and Bacteroides fragilis |
| Description: | Natural product produced by Streptomyces total synthesis; several analogues |
| Year first mentioned: | 1983 |
| Development status: | Experimental |
| Reason dropped: | Enhances ATPase activity of myosin B from skeletal muscle |